Anti-Inflammatory Activity of Bryophytes Extracts in LPS-Stimulated RAW264.7 Murine Macrophages.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
17 Mar 2022
Historique:
received: 13 02 2022
revised: 26 02 2022
accepted: 12 03 2022
entrez: 26 3 2022
pubmed: 27 3 2022
medline: 31 3 2022
Statut: epublish

Résumé

Bryophytes produce rare and bioactive compounds with a broad range of therapeutic potential, and many species are reported in ethnomedicinal uses. However, only a few studies have investigated their potential as natural anti-inflammatory drug candidate compounds. The present study investigates the anti-inflammatory effects of thirty-two species of bryophytes, including mosses and liverworts, on Raw 264.7 murine macrophages stimulated with lipopolysaccharide (LPS) or recombinant human peroxiredoxin (hPrx1). The 70% ethanol extracts of bryophytes were screened for their potential to reduce the production of nitric oxide (NO), an important pro-inflammatory mediator. Among the analyzed extracts, two moss species significantly inhibited LPS-induced NO production without cytotoxic effects. The bioactive extracts of

Identifiants

pubmed: 35335304
pii: molecules27061940
doi: 10.3390/molecules27061940
pmc: PMC8953629
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Lipopolysaccharides 0
Plant Extracts 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Union
ID : 765115
Organisme : Agence Nationale de la Recherche
ID : Lorraine université d'excellence
Organisme : Région Grand Est
ID : FRCR

Références

Plants (Basel). 2021 Jan 21;10(2):
pubmed: 33494524
Nat Med. 2012 Jun;18(6):911-7
pubmed: 22610280
Nat Rev Immunol. 2020 Feb;20(2):95-112
pubmed: 31558839
Nature. 2008 Jul 24;454(7203):428-35
pubmed: 18650913
Trends Immunol. 2015 Mar;36(3):161-78
pubmed: 25687683
PLoS One. 2016 Oct 7;11(10):e0164586
pubmed: 27716839
Cell Chem Biol. 2018 May 17;25(5):550-559.e3
pubmed: 29551349
ACS Catal. 2020 Mar 6;10(5):3326-3339
pubmed: 32363077
Ecol Evol. 2018 Aug 22;8(17):9105-9117
pubmed: 30271570
Int Immunopharmacol. 2016 Dec;41:82-89
pubmed: 27821296
Prog Lipid Res. 2006 Jul;45(4):334-56
pubmed: 16678271
Int Immunopharmacol. 2018 Jul;60:141-151
pubmed: 29730557
Nat Rev Immunol. 2014 May;14(5):289-301
pubmed: 24722477
Front Immunol. 2018 Oct 16;9:2379
pubmed: 30459758
Front Immunol. 2019 Jul 03;10:1462
pubmed: 31333642
J Tradit Complement Med. 2016 Apr 04;7(1):94-98
pubmed: 28053893
Mol Cells. 2016 Jan;39(1):60-4
pubmed: 26813661
Int J Nanomedicine. 2019 Apr 26;14:2945-2959
pubmed: 31114201
Phytomedicine. 2019 Jun;59:152789
pubmed: 31009851
Annu Rev Pathol. 2020 Jan 24;15:493-518
pubmed: 31675482
Plants (Basel). 2021 Jun 22;10(7):
pubmed: 34206653
Free Radic Biol Med. 2015 Nov;88(Pt B):189-198
pubmed: 25968070
Future Sci OA. 2015;1(1):
pubmed: 26634146
J Ethnopharmacol. 2021 Nov 15;280:114452
pubmed: 34311061
Int J Mol Med. 2014 Oct;34(4):1101-9
pubmed: 25109657
J Nat Prod. 1993 Jul;56(7):1071-7
pubmed: 8377015

Auteurs

Raíssa Volpatto Marques (RV)

Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltoft Plads 223, 2800 Kongens Lyngby, Denmark.

Stefania Enza Sestito (SE)

UMR 7365 CNRS, Ingénierie Moléculaire et Physiopathologie Articulaire IMoPA, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.

Frédéric Bourgaud (F)

Plant Advanced Technologies, 19 Avenue de la Forêt de Haye, 54500 Vandœuvre-lès-Nancy, France.
Cellengo, 19 Avenue de la Forêt de Haye, 54500 Vandœuvre-lès-Nancy, France.

Sissi Miguel (S)

Cellengo, 19 Avenue de la Forêt de Haye, 54500 Vandœuvre-lès-Nancy, France.

Frédéric Cailotto (F)

UMR 7365 CNRS, Ingénierie Moléculaire et Physiopathologie Articulaire IMoPA, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.

Pascal Reboul (P)

UMR 7365 CNRS, Ingénierie Moléculaire et Physiopathologie Articulaire IMoPA, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.

Jean-Yves Jouzeau (JY)

UMR 7365 CNRS, Ingénierie Moléculaire et Physiopathologie Articulaire IMoPA, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.

Sophie Rahuel-Clermont (S)

UMR 7365 CNRS, Ingénierie Moléculaire et Physiopathologie Articulaire IMoPA, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.

Sandrine Boschi-Muller (S)

UMR 7365 CNRS, Ingénierie Moléculaire et Physiopathologie Articulaire IMoPA, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.

Henrik Toft Simonsen (HT)

Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltoft Plads 223, 2800 Kongens Lyngby, Denmark.

David Moulin (D)

UMR 7365 CNRS, Ingénierie Moléculaire et Physiopathologie Articulaire IMoPA, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH